Skip to content
Home/Companies/Software/IB WORKS I

IB WORKS I

Software·France·Exited 2024·Held 2yr
Entry
2022
Hold
2yr
Exit
2024

Who owns IB WORKS I?

IB WORKS I was owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage) from 2022 to 2024.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQFrance
SectorSoftware
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2024

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Arzeda
Active
BiotechUS· 2022
Prometheus Materials
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Novameat
Active
BiotechSpain· 2021
Qorium
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021
Protera
Protera
Active
BiotechUS· 2020

More PE-backed in Software

Comparable software deals from other GPs.

1E
1E
Exited 2025
The Carlyle GroupUK
to
2nd Story Software, Inc.
Active
TA AssociatesUS
2ndWave Software
2ndWave Software
Active
PSG EquityUS
360 ONE
Active
General AtlanticUS
3D ISSUE Ltd
3D ISSUE Ltd
Active
Enterprise IrelandIreland
3P
3P
Active
EurazeoBelgium
Track IB Works I

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy IB Works I?

1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on IB Works I.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue